In this report, we provide the first evidence demonstrating a causative role for COX-2-mediated PGE2 signaling in cisplatin-induced cognitive deficits, and a therapeutic potential for NS398-mediated COX-2 inhibition in preventing cisplatin-induced cognitive impairment. Here, PTGS2 is linked to Cognitive impairment.